https://www.selleckchem.com/pr....oducts/limertinib.ht
inclusion of PARP inhibitors in future clinical trials may be considered. Participating in physical activity after a diagnosis of cancer is associated with reduced morbidity and improved outcomes. However, declines in, and low levels of, physical activity are well documented in the broader cancer population, but with limited evidence following gynecological cancer. To describe physical activity levels from before and up to 2 years after gynecological cancer surgery; to explore the relationship between physical activity patterns and q
Like
Comment
Share
